174 related articles for article (PubMed ID: 18357774)
1. The CVB and etiology of type 1 diabetes.
Drescher KM; Tracy SM
Curr Top Microbiol Immunol; 2008; 323():259-74. PubMed ID: 18357774
[TBL] [Abstract][Full Text] [Related]
2. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
[TBL] [Abstract][Full Text] [Related]
3. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Sané F; Moumna I; Hober D
Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes.
Richer MJ; Horwitz MS
Autoimmun Rev; 2009 Jun; 8(7):611-5. PubMed ID: 19393207
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
[TBL] [Abstract][Full Text] [Related]
6. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
Tracy S; Drescher KM
Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
[TBL] [Abstract][Full Text] [Related]
7. [Coxsackievirus B infection and pathogenesis of type 1 diabetes].
Nekoua MP; Mercier A; Vergez I; Morvan C; Mbani CJ; Sane F; Lobert D; Engelmann I; Romond MB; Alidjinou EK; Hober D
Virologie (Montrouge); 2022 DéCembre 01; 26(6):415-430. PubMed ID: 36565260
[TBL] [Abstract][Full Text] [Related]
8. Group B coxsackievirus virulence.
Tracy S; Gauntt C
Curr Top Microbiol Immunol; 2008; 323():49-63. PubMed ID: 18357765
[TBL] [Abstract][Full Text] [Related]
9. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship.
Jaïdane H; Sauter P; Sane F; Goffard A; Gharbi J; Hober D
Rev Med Virol; 2010 Sep; 20(5):265-80. PubMed ID: 20629044
[TBL] [Abstract][Full Text] [Related]
10. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B.
Hyöty H; Leon F; Knip M
Expert Rev Vaccines; 2018 Dec; 17(12):1071-1083. PubMed ID: 30449209
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models.
Jaïdane H; Sané F; Gharbi J; Aouni M; Romond MB; Hober D
Diabetes Metab Res Rev; 2009 Oct; 25(7):591-603. PubMed ID: 19621354
[TBL] [Abstract][Full Text] [Related]
12. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.
Jaïdane H; Hober D
Diabetes Metab; 2008 Dec; 34(6 Pt 1):537-48. PubMed ID: 18951821
[TBL] [Abstract][Full Text] [Related]
13. The role of viruses in the etiopathogenesis of diabetes mellitus.
Strycharz M; Bartecka K; Polz-Dacewicz M
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):257-60. PubMed ID: 16145992
[TBL] [Abstract][Full Text] [Related]
14. The role of B lymphocytes in coxsackievirus B3 infection.
Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
[TBL] [Abstract][Full Text] [Related]
15. Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis.
Jaïdane H; Sané F; Hiar R; Goffard A; Gharbi J; Geenen V; Hober D
Clin Exp Immunol; 2012 Apr; 168(1):39-46. PubMed ID: 22385235
[TBL] [Abstract][Full Text] [Related]
16. Viral infection of engrafted human islets leads to diabetes.
Gallagher GR; Brehm MA; Finberg RW; Barton BA; Shultz LD; Greiner DL; Bortell R; Wang JP
Diabetes; 2015 Apr; 64(4):1358-69. PubMed ID: 25392246
[TBL] [Abstract][Full Text] [Related]
17. Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes.
Alidjinou EK; Sané F; Engelmann I; Geenen V; Hober D
Discov Med; 2014 Nov; 18(100):273-82. PubMed ID: 25425468
[TBL] [Abstract][Full Text] [Related]
18. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes.
Laitinen OH; Honkanen H; Pakkanen O; Oikarinen S; Hankaniemi MM; Huhtala H; Ruokoranta T; Lecouturier V; André P; Harju R; Virtanen SM; Lehtonen J; Almond JW; Simell T; Simell O; Ilonen J; Veijola R; Knip M; Hyöty H
Diabetes; 2014 Feb; 63(2):446-55. PubMed ID: 23974921
[TBL] [Abstract][Full Text] [Related]
20. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes.
Oikarinen S; Tauriainen S; Hober D; Lucas B; Vazeou A; Sioofy-Khojine A; Bozas E; Muir P; Honkanen H; Ilonen J; Knip M; Keskinen P; Saha MT; Huhtala H; Stanway G; Bartsocas C; Ludvigsson J; Taylor K; Hyöty H;
Diabetes; 2014 Feb; 63(2):655-62. PubMed ID: 24009257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
